title: Indicators of fibrinolysis during cardiopulmonary bypass after exogenous antithrombin-III administration for acquired antithrombin III deficiency.
authors.affiliation: Department of Anesthesiology, University of Washington, Seattle 98195, USA.
authors.forename: G A
authors.initials: GA
authors.lastname: Van Norman
authors.forename: T
authors.initials: T
authors.lastname: Gernsheimer
authors.forename: W L
authors.initials: WL
authors.lastname: Chandler
authors.forename: R P
authors.initials: RP
authors.lastname: Cochran
authors.forename: B D
authors.initials: BD
authors.lastname: Spiess
mesh_terms: D000990:Antithrombin III / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D002315:Cardiopulmonary Bypass; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood
chemical_list: D017395:Plasminogen Activator Inhibitor 1; D000990:Antithrombin III